KJIM :: Korean Journal of Internal Medicine

Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues

Clara Appiah, Shitian Chen, Afia Ibnat Pori, Vladimir Retyunskiy, Chimeng Tzeng, Ye Zhao

Perspectives on chemotherapy-induced toxicities in pancreatic cancer

Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs

Sarah Brumskill, Lawrence N. Barrera, Peter Calcraft, Caroline Phillips, Eithne Costello

Journal of Physiology and Biochemistry.2023; 79(1): 223. CrossRef

Nanocarriers targeting the diseases of the pancreas

European Journal of Pharmaceutics and Biopharmaceutics.2022; 170: 10. CrossRef

Gemcitabine-Induced Hemolytic Uremic Syndrome in Lung Cancer: A Case Report

Prashant Ahlawat, Monica Gupta, Prateek Upadhyay, Shivani Gupta, Amanjot Kaur

Overcoming immunotherapeutic resistance in PDAC: SIRPα-CD47 blockade

Abdullahi Alausa, Khadijat Ayodeji Lawal, Oluwakemi Arinola Babatunde, E.N.O. Obiwulu, Olajumoke Christianah Oladokun, Olumide Samuel Fadahunsi, Ugwu Obiora Celestine, Emmanuel Ugbede Moses, Ifunanya Rejoice Akaniro, Peter Ifeoluwa Adegbola

Pharmacological Research.2022; 181: 106264. CrossRef

Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer Therapies

Andreia S. Fernandes, Catarina Oliveira, Rui L. Reis, Albino Martins, Tiago H. Silva

α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma

Caixia Liang, Tomohiko Fukuda, Tomoya Isaji, Chengwei Duan, Wanli Song, Yuqin Wang, Jianguo Gu

Biochimica et Biophysica Acta (BBA) - General Subjects.2021; 1865(6): 129870. CrossRef

FOLFIRINOX in adjuvant and metastatic settings for pancreatic cancer in the era of precision oncology

Anda Crişan, Liliana Eleonora Semenescu, Ciprian Camil Mireştean, Adina Mitrea, Irina Roxana Iancu, Dragoş Petru Teodor Iancu

Mechanistic Actions between Garcinia atroviridis Essential Oil and 2 Deoxy-d-glucose in Cultured PANC-1 Human Pancreatic Cancer Cells

Nik Nur Syazni Nik Mohamed Kamal, Fatin Athirah Abdul Aziz, Wen-Nee Tan, Agustine Nengsih Fauzi, Vuanghao Lim

First experience of using combination of conformal radiation therapy with intraarterial administration of gemcitabine and nanostabilized paclitaxel in patients with locally advanced pancreatic cancer complicated by persistent chronic pain

A. A. Statsenko, V. E. Moiseenko, A. V. Pavlovsky, S. A. Popov, A. A. Polikarpov, E. V. Vlasova

Inhibition of Pancreatic Cancer Cell Viability and Tumor Growth Through Cell Cycle Arrest by an Oral Formulation of Docetaxel DHP23001

Jung Ae Kang, Jung Hyu Sin, Hye Lim Lee, Hye Rim Kim, Sung Hun Kim, Min-Kyoung Kang, A-Ram Yu, Min-Hee Son, Hye-Jin Park, Jae Jun Lee

International Journal of Pharmacology.2019; 15(8): 994. CrossRef

p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation

Kai Wang, Graham S Baldwin, Mehrdad Nikfarjam, Hong He

World Journal of Gastroenterology.2018; 24(33): 3709. CrossRef

A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts

Orla Coleman, Michael Henry, Fiona O'Neill, Sandra Roche, Niall Swan, Lorraine Boyle, Jean Murphy, Justine Meiller, Neil Conlon, Justin Geoghegan, Kevin Conlon, Vincent Lynch, Ninfa Straubinger, Robert Straubinger, Gerard McVey, Michael Moriarty, Paula Me

Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives

Mina Hosseini, Seyed Mahdi Hassanian, Elham Mohammadzadeh, Soodabeh ShahidSales, Mina Maftouh, Hasan Fayazbakhsh, Majid Khazaei, Amir Avan

Journal of Cellular Biochemistry.2017; 118(7): 1634. CrossRef

Clinical outcomes following stereotactic body radiation therapy (SBRT) for non-resectable pancreatic adenocarcinoma

Journal of Radiation Oncology.2017; 6(3): 279. CrossRef

Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies

Aleksandra Adamska, Alice Domenichini, Marco Falasca

International Journal of Molecular Sciences.2017; 18(7): 1338. CrossRef

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study

Kyung Hee Lee, Min Kyoung Kim, Yeol Hong Kim, Baek Yeol Ryoo, Ho Yeong Lim, Hong Suk Song, Hoon Kyo Kim, Myung Ah Lee, Seock Ah Im, Heung Moon Chang, Jae Yong Cho, Dae Young Zang, Bong Seog Kim, Jun Suk Kim

Cancer Chemotherapy and Pharmacology.2009; 64(2): 317. CrossRef

Fixed Dose Rate Infusion of Gemcitabine with Oral Doxifluridine and Leucovorin for Advanced Unresectable Pancreatic Cancer: A Phase II Study

Hawk Kim, Jae-Hoo Park, Su Jin Shin, Mee-Ja Kim, Sung-Jo Bang, Neung Hwa Park, Yang Won Nah, Chang Woo Nam, Kwang Ro Joo, Young Joo Min